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Human breast cancers cells overexpressing HER2/neu are more aggressive tumors with poor prognosis, and resistance to
chemotherapy. This study investigates antiproliferation eﬀects of anthraquinone derivatives of rhubarb root on human breast
cancer cells. Of 7 anthraquinone derivatives, only rhein showed antiproliferative and apoptotic eﬀects on both HER2-
overexpressing MCF-7 (MCF-7/HER2) and control vector MCF-7 (MCF-7/VEC) cells. Rhein induced dose- and time-dependent
manners increase in caspase-9-mediated apoptosis correlating with activation of ROS-mediated activation of NF-κB- and p53-
signaling pathways in both cell types. Therefore, this study highlighted rhein as processing anti-proliferative activity against HER2
overexpressionorHER2-basalexpressioninbreastcancercellsandplayingimportantrolesinapoptoticinductionofhumanbreast
cancer cells.
1.Introduction
Rhubarb root (Rheum palmatum), member of the Polyg-
onaceae family, is one well-known antineoplastic herb in
traditional Chinese medicine [1]. Anthraquinone derivatives
are its main bioactive constituents: emodin (1,3,8-trihy-
droxy-6-methylanthraquinone), aloe emodin (1,8-dihy-
droxy-3-hydroxyl-methyl anthraquinone), rhein (1,8-dihy-
droxy-3-carboxyanthraquinone), chrysophanol (1,8-dihy-
droxy-3-methyl-anthraquinone), physcion (1,8-drihydroxy-
3-methyl-6-methoxyanthraquinone), and danthron (1,8-
dihydroxy-9,10-anthraquinone). Rhubarb anthraquinone
derivatives can induce apoptosis of human cancer, including
lung adenocarcinoma A549, myelogenous leukemia HL-
60, lung squamous carcinoma CH27, cervical carcinoma
HeLa cells, neuroblastoma IMR-32, bladder cancer T24,
and hepatoma HepG2 cells [1]. Emodin inhibits cellular
proliferation, induces apoptosis, and prevents metastasis
through activation of tyrosine kinases, phosphoinositol 3-
kinase(PI3K),proteinkinaseC(PKC),NF-kappaB(NF-κB),
and mitogen-activated protein kinase (MAPK) signaling cas-
cades [2–5]. Aloe-emodin has antitumor properties through
the p53 and its downstream p21 pathway [6]. Emodin
and aloe emodin also reduce tumor size, prolong survival,
decrease incidence of tumor invasion and neovascularization
using in vivo animal models [7, 8]. Rhein blocks the uptake
of glucose in tumor cells, causing changes in membrane-
associated functions to trigger cell death [9].
Breast cancer is one of the most common cancers in
women, resulting from gene ampliﬁcation and/or overex-
pression of some oncogenes like HER2/neu (also known as
ErbB2) and oestrogen receptors [10, 11]. Overexpression of
HER2/neu in nearly 30% of human breast cancers correlates
with more aggressive tumors and poor prognosis [12]. HER-
2-overexpressing cells appear to be resistant to some classes
of chemotherapy agents [12], but sensitive to others [13].2 Evidence-Based Complementary and Alternative Medicine
Overexpression of HER2/neu was positively correlated with
p53 nuclear accumulation and tumor metastasis, negatively
with hormonal receptor status [14]. Tyrosine kinase activity
of HER2/neu could phosphorylate HER3 and then activate
phosphatidylinositol3-kinase(PI3K)involvedinmalignance
of tumors [15]. Trastuzumab (Herceptin) is widely used
for treatment of HER2-positive breast cancer; resistance
to trastuzumab occurs in some patients [16]. Therefore,
HER2/neuisapotentiallytherapeutictargetforbreastcancer,
inﬂuencing eﬃcacy of chemotherapy.
Engineering human breast cancer MCF-7 cells that ex-
presses basal level of HER2/neu for Overexpression of
HER2/neu has been used to analyze biological properties of
HER2 overexpression [15, 17]. This study investigates apop-
totic eﬀects of anthraquinone derivatives of rhubarb root
on both types of breast cancer cells, HER2-overexpressing
MCF-7 cells (MCF-7/HER2) and control vector MCF-7 cells
(MCF-7/VEC). Of 7 anthraquinone derivatives, only rhein
showed antiproliferative and apoptotic eﬀects on both MCF-
7/HER2 and MCF-7/VEC cells. We also analyzed apoptotic
mechanism of rhein on both human breast cancer cell lines
with basal level and Overexpression of HER2.
2.MaterialsandMethods
2.1. Cell Culture. Human breast cancer cell lines, vector con-
trol MCF-7 cells (MCF-7/VEC) and HER2-overexpressing
MCF-7 cells (MCF-7/HER2), were used in this study, as pre-
viously described [15]. Both types were grown in DMEM/F-
12 (Invitrogen) with 10% fetal bovine serum (Invitrogen),
gentamicin (50mg/mL) and G418 (800μg/mL).
2.2. Western Blotting Analysis. Cell lysates that were har-
vested from MCF-7/VEC and MCF-7/HER2 cells with or
without treatment of anthraquinone derivatives were dis-
solved in 2X SDS-PAGE sample buﬀer without 2-mercap-
toethanol, and boiled for 10min. Cell lysate proteins were
resolved on 12% SDS-PAGE gels and transferred to nitrocel-
lulosepaper.Resultantblotswereblockedwith5%skimmilk
and reacted with properly diluted monoclonal antibodies
against HER2/c-neu (Ab-3,3B5), caspase 9, Apoptosis signal-
regulating kinase 1 (ASK1), P21, and β-actin (Cell Signaling
Technology) for 3h incubation. Immune complexes were
detected by horseradish peroxidase-conjugated goat anti-
mouse IgG antibodies, followed by enhanced chemilumines-
cence reaction (Amersham Pharmacia Biotech).
2.3. MTT Cytotoxicity Test. Aloe emodin, emodin, rhein,
chrysophanol, sennoside A, sennoside B, and 9-, 10-an-
thraquinone were purchased from Sigma Chemical Com-
pany (St. Louis, MO, USA). In vitro antiproliferative eﬀect
of each compound on MCF-7/VEC and MCF-7/HER2 cells
was examined using MTT assay. Cells were plated in 96-
well plates (5 × 104 cells/well) and then treated with serial
dilution of each tested compound. After treatment for 48h,
25μLo faM T Ts o l u t i o na t5 m g / m Lw a sa d d e dt oe a c h
well and incubated at 37◦Ci n5 %C O 2 for 3h. After
subsequentwashingthreetimeswithphosphatebuﬀersaline,
100μL DMSO was added into plates for dissolving formazan
crystals. OD570−630 in each well was measured with a micro-
ELISA reader and survival rate used to indicate suppressive
eﬀectsofeachcompoundonMCF-7/VECandMCF-7/HER2
cells. Survival rate (%) = ((Acontrol − Aexperiment)/Acontrol) ×
100%. Cytotoxic concentration giving 50% (CC50) was
calculated by computer program (provided by John Spouge,
NCBI, NIH).
2.4. Detection of Cell Cycle and Apoptosis by Flow Cytometry.
MCF-7/VEC and MCF-7/HER2 cells were harvested 24,48,
and 72h posttreatment with or without serial dilutions of
rhein. Cells were ﬁxed using 70% ethanol at 4◦C overnight,
then re-suspended in PBS containing 50μg/mL PI and
0.1mg/mL RNase and 0.1% Triton X-100 in darkroom.
After 30min incubation at 37◦C, cells were tested by
ﬂow cytometry (Becton-Dickinson, San Jose, Calif, USA)
equipped with an argon ion laser at 488nm wavelength, then
rates of sub G1 (apoptotic), G1, S, and G2 phase cells were
determined. In addition, rhein-induced cytopathic eﬀect
(CPE) of MCF-7/VEC and MCF-7/HER2 cells was observed
48h posttreatment using light microscopy.
2.5. Detecting Intracellular Reactive Oxygen Species (ROS) by
Flow Cytometry. MCF-7/VEC and MCF-7/HER2 cells were
harvested 24h posttreatment with or without serial dilutions
of rhein; 5 × 105 cells were harvested after 48h transfection
andtheirROSlevelnoted.TheywerewashedtwicewithPBS,
then incubated with 10μM 2,7-dichlorodihydroﬂuorescein
diacetate (DCFH-DA, Sigma) at 37◦Cf o r3 0 m i ni nd a r k -
room for ﬁnal analysis by ﬂow cytometry (Becton Dickinson
FACS Calibur).
2.6. In Vivo Signaling Transduction Pathway Assay with
Cis-Reporter Plasmids. Cis-reporter plasmids pAP1- Luc,
pNF-κB-Luc, and p53-Luc were purchased from Stratagene
Company. MCF-7/VEC and MCF-7/HER2 cells were co-
transfected with cis-reporter plasmid and internal control
reporterpRluc-C1(BioSignalPackard)in6-wellplates,using
the Arrest-In transfection reagent. After one-day incubation,
transfected cells were seeded into 24-well plates using the
MEM containing 10% FBS, then treated with or without
20μg/mL rhein. After 4h posttreatment, enzyme activity of
ﬁreﬂy and Renilla luciferases in indicated cells was measured
by dual Luciferase Reporter Assay System (Promega) and
Luminometer TROPIX TR-717 (Applied Biosystems). Rel-
ative ﬁreﬂy luciferase activity of the cis-acting reporter was
normalized by Renilla luciferase.
2.7. Statistical Analysis. ANOVA analysis using SPSS pro-
gram (version 10.1, SPSS Inc., IL, USA) or Student’s t-
test analyzed data, P value below 0.05 were considered sta-
tistically signiﬁcant.
3. Results and Discussion
3.1. Rhein Inhibited Growth of MCF-7/VEC and MCF-
7/HER2 Cells in Dose-Dependent Manner. To examineEvidence-Based Complementary and Alternative Medicine 3
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Figure 1: Expression of HER2/neu in human breast cancer
cells. Vector control MCF-7 cells (MCF-7/VEC) and HER2-
overexpressing MCF-7 cells (MCF-7/HER2) were harvested, and
cell lysates were analyzed by Western blotting with anti-HER2 and
anti-β actin antibodies.
expression level of HER2 in MCF-7/VEC and MCF-7/HER2
cells, both cell lysates were analyzed using Western blotting
assay. Immunoreactive bands with anti-HER2 antibodies
revealed basal expression of HER2 in MCF-7/VEC cells
and Overexpression of HER2 in MCF-7/HER2 cells (Fig-
ure 1, Lanes 1 and 2). Subsequently, antiproliferative eﬀect
of anthraquinone derivatives on MCF-7/VEC and MCF-
7/HER2 cells was analyzed using MTT assay (Figure 2).
Sennosides A and B have no inhibitory eﬀect on cell growth,
while IC50 values of 9-, 10-anthraquinone, chrysophanol,
aloe emodin, and emodin for both types of cells exceeded
100μg/mL (Table 1). Only rhein had a dose-dependent
antiproliferative ability on both types. In addition, rhein
was less toxic to nontumorigenic MCF-10A cells used as
the normal control (Figure 1 of the Supplementary material
available online at doi:10.1155/2012/940920). The IC50
value of rhein was 36.69 ± 9.77μg/mL (129.1 ± 34.37μM)
for MCF-7/VEC cells and 30.66 ± 2.21μg/mL (107.9 ±
7.7μM) for MCF-7/HER2 cells. Rhein showed micromolar
IC50 values on growth suppression of MCF-7/VEC and
MCF-7/HER2 cells, similar to antiproliferative activity of
rhein lysinate on human breast cancer cell lines MCF-7,
SK-Br-3, and MDA-MB-231 [18] and human hepatocellular
carcinoma BEL-7402 cells [19], but less potent than its
activity against tongue cancer cell line SCC-4 [20]a n d
ovarian carcinoma cell line SKOV-3 [21].
3.2. Rhein Inﬂuenced Cell Cycle Phase of MCF-7/VEC and
MCF-7/HER2 Cells. To examine the eﬀect of rhein on
cell cycle phases, both types were treated with or without
rhein at concentrations of 10μg/mL and 100μg/mL, and
then harvested 24, 48, and 72 hours posttreatment. Cells
were stained with propidium iodide and analyzed for cell
cycle fractions by ﬂow cytometry (Figure 3). Rhein induced
concentration- and time-dependent manner increase in sub-
G1 (apoptosis) fractions of MCF-7/VEC and MCF-7/HER2
cells (P<0.05, Figure 3(a)). The rate of G1 phase in MCF-
7/VEC cells signiﬁcantly increased 24 hours posttreatment
with rhein at a concentration of 100μg/mL (P<0.05),
but no eﬀect of rhein on G1 phase in MCF-7/HER2 cells
was detected (Figure 3(b)). Rhein at concentrations of 10
and 100μg/mL caused a signiﬁcant S phase arrest in MCF-
7/HER2 cells 48 and 72 hours posttreatment (P<0.05),
but rhein at a concentration of 100μg/mL decreased S phase
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Figure 2: Eﬀect of anthraquinone derivatives on the growth of
human breast cancer cells. MCF-7/VEC (a) and MCF-7/HER2
(b) cells were plated in 96-well plates (5 × 104 cells/well) and
then treated with serial dilution of each tested compound. After
treatment for 48h, cell growth was examined using MTT assay.
OD570−630 in each well was measured with a micro-ELISA reader.
Survival rate (%) = ((Acontrol − Aexperiment)/Acontrol) × 100.
∗P value < 0.05; ∗∗P value < 0.01 compared with untreated cells.
fractionsin MCF-7/VEC cells24 and48 hoursposttreatment
(P< 0.05, Figure 3(c)). Interestingly, a very low fraction of
G2phasewasdetectedinMCF-7/HER2cells48and72hours
posttreatment with rhein at a concentration of 100μg/mL
(P<0.05); no signiﬁcant change appeared in MCF-7/VEC
cells 24, 48, and 72 hours posttreatment (Figure 3(d)).
Cell cycle analysis demonstrated rhein inducing S phase
arrest and G2 phase decrease in MCF-7/HER2 cells (Figures
3(c) and 3(d)). Moreover, rhein increased the rate of G1
phase, but decreased the fraction of S phase in MCF-
7/VEC cells (Figures 3(b) and 3(c)). The diﬀerence of cell
cycle distribution in response to rhein could be due to cell4 Evidence-Based Complementary and Alternative Medicine
Table 1: IC50 values of anthraquinone derivatives in MCF-7/VEC and MCF-7/HER2 cells.
Compounds Structure IC50
MCF-7/VE C MCF-7/HER2
Rhein
O
O O
OH
HO
OH
36.69 ±9.77μg/mL (129.1μM) 30.66 ± 2.21μg/mL (107.9μM)
Alo-emodin
O
O
HO
OH OH >1000μg/mL 87.2 ± 12.0μg/mL (322.7μM)
Emodin
O
OH
OH OH
O >1000μg/mL 306.68 ± 6.57μg/mL (1134.8μM)
Chrysophanol
O OH OH
O >1000μg/mL >1000μg/mL
9,10-anthra quinone
O
O >1000μg/mL >1000μg/mL
speciﬁcity [22, 23]. Cell cycle analysis of breast cancer BT-
474 cells and MCF-7 cells indicated 1alpha(OH)D5 inducing
an S phase decrease in MCF-7 cells and a G2 phase decrease
in BT-474 cells [22].Moreover,resveratrolinducedapoptosis
of MCF-7 cells via S phase arrest, but not MDA-MB-231 cells
[23]. Western blot analysis indicated activation of caspase 9
in both cell types (Figure 4), responsible for dose-dependent
manners on rhein-induced apoptosis of breast cancer cells.
Results demonstrate that S phase arrest of MCF-7/HER2
cells and increased G1 phase of MCF-7/VEC cells correlated
with rhein-induced caspase-9-mediated apoptosis. Rhein-
induced S phase arrest of MCF-7/HER2 cells correlates
with antiproliferative and apoptotic mechanisms of rhein
on human hepatocellular and tongue carcinoma cells [19,
24]. Also, G1 arrest of MCF-7/VEC cells induced by rhein
proves consistent with rhein-induced apoptosis of human
lung cancer A-549 cells [25] and cervical cancer Ca Ski cells
[26].
3.3. Rhein Induced ROS-Mediated Activation of ASK1 in
MCF-7/VECandMCF-7/HER2Cells. IntracellularROSgen-
eration reportedly triggers activation of caspase 9 and ASK1
signaling in apoptotic responses [27–29]. Therefore, we
assessed eﬀects of rhein treatment on intracellular ROS
and ASK1 levels in MCF-7/VEC and MCF-7/HER2 cells
(Figures 5 and 6). Cells were cultured with rhein at 37◦C
for 48 hours. After being washing twice with PBS, cells were
stained with DCFH-DA, then analyzed by ﬂow cytometry.
Rhein treatment caused concentration-dependent increase
of intracellular ROS in MCF-7/VEC and MCF-7/HER2 cells
(P<0.05, Figure 5). Western blot with anti-ASK1 antibod-
ies revealed rhein as concentration-dependently triggering
ASK1 level in each type of cell (Figure 6). Results indicate
ROS-mediatedASK1signaling inrhein-induced apoptosis of
both types. The ﬁndings were in agreement with incremental
level of intracellular ROS in rhein-induced apoptosis of
human tongue cancer cells, promyelocytic leukemia cells,
and nasopharyngeal carcinoma cells [24, 30, 31].
3.4. Rhein Activated p53/p21 Signaling in MCF-7/VEC and
MCF-7/HER2 Cells. To probe correlation between in vivo
signaling pathways and rhein-induced growth arrest and
apoptosis, cells in response to rhein were further character-
ized by dual reporter assays with internal control reporter
pRluc-C1 and luciferase reporter plasmid containing direct
repeat elements of AP1, NF-κB, and p53 (Figure 7). The
cells were harvested 4h posttreatment, and then the relative
expression of ﬁreﬂy luciferase driven from the indicated
cis-reporter plasmid was normalized by Renilla luciferase.Evidence-Based Complementary and Alternative Medicine 5
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Figure 3: Cell cycle analysis of human breast cancer cells in response to rhein. MCF-7/VEC and MCF-7/HER2 cells were treated with serial
dilution of rhein. After 24, 48, and 72h incubation, cells were ﬁxed by 70% ethanol, stained with PI, and analyzed using ﬂow cytometry.
PercentageofcellsinsubG1(apoptotic)(a),G1(b),S(c),andG2(d)phaseswereshownrepresentingthreeindependentstudies. ∗P value <
0.05; ∗∗P value < 0.01 compared with untreated cells.
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Figure 4: Western blotting analysis of caspase 9 in human breast
cancer cells with/without rhein treatment. After 48h incubation
with rhein, MCF-7/VEC and MCF-7/HER2 cells were harvested,
and lysates were analyzed by Western blotting with anticaspase-9
and anti-β actin antibodies.
Relative intensity of ﬁreﬂy luciferase revealed that rhein
signiﬁcantlyactivatedp53-andNF-κBpr omoters(P<0.05),
but induced no signiﬁcant change of AP1-derived reporter
activityineachtypeofcell(Figure7). Moreover, p53- or NF-
κB-derived reporter activity increased more than 1.7-fold
in rhein-treated cells than mock cells. Deﬁnite increase of
rhein-induced NF-κB- and p53-derived reporter activity in
both types of cells indicated rhein modulating NF-κB- and
p53-signaling pathways in breast cancer cells. Our result was
inconsistent with the function of NF-κB mediating the cell
survivalresponsebyinhibitingp53-dependentapoptosisand
upregulatinganti-apoptoticmembersoftheBcl2family[32].
However, recent evidences show pro-apoptotic property
of NF-κB via p53-dependent apoptosis in breast cancer
MCF7/ADR, melanoma M14, and pro-B cells [33–36]. Acti-
vationofNF-κBinducesupregulationofpro-apoptoticdeath
receptor 5 (DR5) in breast cancer MCF-7 and MDA-MB-
231 cells, correlating with TNF-related apoptosis inducing6 Evidence-Based Complementary and Alternative Medicine
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Figure 5: Flow cytometric analysis of reactive oxygen species
(ROS) in human breast cancer cells with/without rhein treatment.
After 24 and 48h incubation with rhein, MCF-7/VEC and MCF-
7/HER2 cells were harvested, and then stained by DCFH-DA dye.
The ﬂuorescence intensity of stained cells was determined by ﬂow
cytometry. ∗P value < 0.05; ∗∗P value < 0.01 compared with
untreated cells.
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Figure 6: Western blotting analysis of ASK1 expression in human
breast cancer cells with/without rhein treatment. After 48h incu-
bation with rhein, MCF-7/VEC and MCF-7/HER2 cells were
harvested, and lysates were analyzed by Western blotting with anti-
ASK1 and anti-β actin antibodies.
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Figure 7:Eﬀect of rhein on in vivo signal pathways in human breast
cancer cells. MCF-7/VEC and MCF-7/HER2 cells were transiently
co-transfected with cis-reporter plasmids (pAP1-Luc, pNF-κB-Luc,
andp53-Luc)andaninternalcontrolreporter(pRluc-C1),andthen
treated with rhein for 24h. Fireﬂy and Renilla Luciferase enzymes
were measured; the relative ﬁreﬂy luciferase activity was normalized
by Renilla Luciferase. ∗P value < 0.05; ∗∗P value < 0.01 compared
with untreated cells.
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Figure 8: Western blotting analysis of p21 expression in human
breast cancer cells with/without rhein treatment. After 48h incu-
bation with rhein, MCF-7/VEC and MCF-7/HER2 cells were
harvested, and lysates were analyzed by Western blotting with anti-
p21 and anti-β actin antibodies.
ligand-mediated apoptosis [37]. In addition, oxidative stress
hasdemonstratedactivationofbothNF-κBandp53[38,39].
Doxycycline-induced superoxide-mediated apoptosis indi-
cated NF-κB as a proapoptotic factor by activating the p53-
signaling pathway [39]. Monoamine neurotoxin-induced
apoptosis of peripheral blood lymphocytes is associated with
activation of NF-κB, p53, and c-Jun transcription factors
[40]. Thus, rhein-induced activation of both NF-κB- and
p53-signaling pathways might correlate with ROS-mediated
ASK1 signaling in breast cancer cells (Figures 5 and 6).
Moreover, rhein has reported activation of p53/p21 signaling
pathway with in rhein-induced apoptosis of human lung
cancer cells, cervical cancer cells, and hepatoblastoma cells
[25, 26, 41]. We also demonstrated rhein-inducing dose-
dependent increases of p21 protein in MCF-7/VEC and
MCF-7/HER2 cells (Figure 8). Therefore, rhein-induced
apoptosisofbreastcancercellscouldbeassociatedwithROS-
mediated activation of NF-κB- and p53-signaling pathways.
In conclusion, this study highlighted rhein versus six
other anthraquinone derivatives, as processing antiprolif-
erative activity against both types of breast cancer cells
with HER2 overexpression or HER2-basal expression. Rhein
showed micromolar IC50 values on growth inhibition of
both types via caspase-9-mediated apoptosis. ROS-mediated
activation of NF-κB- and p53-signaling pathways might play
important roles in rhein-induced apoptosis of human breast
cancer cells.
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